Thus, we at first attempted to determine the expression profile of ADAMs in HBL tissues compared with that in noncancerous liver (NCL) by using a cDNA microarray dataset that includes data from patients with HBL, and found that ADAM32 was expressed predominantly in HBL tissue. Here, ADAM32 is linked to hepatoblastoma.